Great Bay Bio to Showcase AI-Driven Cell Line Development Platform at ASGH 2026

Asia's Premier Health Innovation and Investment Summit – The Asia Summit on Health (ASGH) – Will Be Held at the Hong Kong Convention and Exhibition Centre on May 11-12.This forum, jointly organized by the Hong Kong Special Administrative Region Government and the Hong Kong Trade Development Council with the theme "Driving New Breakthroughs in Healthcare," gathers government officials responsible for global healthcare, business leaders, investors, service providers, international scientific research and medical experts, etc., to examine the latest trends in healthcare innovation and investment, explore cooperation opportunities in the healthcare sector internationally, and showcase various business opportunities for investors and project owners.

▲ Asian Medical and Health Forum (ASGH)

Mr. Guolong Liang, Co-founder and Chairman of Great Bay Bio, was invited to attend this grand event.Will deeply share GBB's site-specific integration + AI-driven core technology, revolutionizing the entire process of next-generation stable and high-efficiency cell line development, helping customers develop products faster and better, accelerating towards engineering and commercialization, making global bioprocess development simpler and more efficient.

GBB Booth No.: 3F-G02, sincerely welcomes industry experts and colleagues from home and abroad to visit the booth for exchange and discussion.(GBB is an important participant of this exhibition, with a limited number of standard tickets available. You can reserve and collect them from us through the contact information at the end of the article.)

▲GBB Booth No.: 3F-G02